Rapt Therapeutics, Inc. (RAPT)

35.90 +0.50 (+1.41%) USD  |  NASDAQ  |  Dec 24, 12:59
35.90 0.00 (0.00%) After-Hours: 13:59
More

Rapt Therapeutics SG&A Expense (TTM): 29.76M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Replimune Group, Inc. 102.36M
Olema Pharmaceuticals, Inc. 18.61M
NovaBay Pharmaceuticals, Inc. 8.584M
Palatin Technologies, Inc. 7.449M
Theriva Biologics, Inc. 16.21M